Morgan, Robert D <br/><br/>
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  04 2018 
 - 647-658 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-018-3532-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cystadenocarcinoma, Serous--drug therapy<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Ovarian Neoplasms--drug therapy<br/>Platinum--administration & dosage<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use